TAK-CIRCULATOR CO., LTD
2Patents
2Active
2Granted
41Portfolio score
Filing activity: Jul 7, 2017 → Jul 7, 2017
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11312956B2 | Nucleic acid inhibiting expression of the MEX3B gene, MEX3B gene expression inhibitor, method for inhibiting MEX3B gene expression, and prophylactic or therapeutic agent for disease caused by MEX3B gene expression | Chemistry; Metallurgy | 1 | Active |
| US11279935B2 | Method for screening prophylactic or therapeutic agents for diseases caused by interleukin 6, interleukin 13, TNF, G-CSF, CXCL1, CXCL2, or CXCL5 and agent for the prevention or treatment of diseases caused by interleukin 6, interleukin 13, TNF, G-CSF, CXCL1, CXCL2, or CXCL5 | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.